Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cells

International Journal of Cancer - Tập 48 Số 6 - Trang 866-872 - 1991
S C Mann1, Paul A. Andrews, Stephen B. Howell
1Department of Medicine, University of California, San Diego, La Jolla 92093.

Tóm tắt

AbstractWe have determined the effect of forskolin, an adenyl cyclase agonist, and 3‐isobutyl‐1‐methylxanthine (IBMX), a phosphodiesterase inhibitor, on the accumulation and cyto‐toxicity of cisplatin (DDP) In 2008 human ovarian carcinoma cells. In DDP‐sensitive 2008 cells, forskolin and IBMX caused 2.1‐fold and 2.3‐fold Increases, respectively, in the short‐term accumulation of DDP relative to untreated cells. The inactive analogue, 1,9‐dideoxyforskolin, decreased DDP accumulation. Forskolin and IBMX also increased accumulation in A2780 cells. Neither forskolin nor IBMX had any effect on DDP accumulation in DDP‐resistant 2008 cells, the effects were detectable as early as I min and persisted at 60 min. The concentrations for half‐maximal stimulation of DDP accumulation were approximately 0.2 μM for forskolin and 0.2 mM for IBMX. Forskolin caused marked increases in cAMP levels in both sensitive and resistant 2008 cells within I min, although there were differences in the subsequent time‐courses of the response. Both 2008 cell types had identical cAMP‐dependent protein kinase (PKA) activity. These results suggest that there is a target downstream of PKA that is an Important participant in DDP accumulation, and that this target is defective of missing in DDP‐resistant cells. Following a 1‐hr exposure to drugs, forskolin and IBMX at concentrations that were by themselves completely non‐toxic increased the slopes of the clonogenic survival vs. DDP concentration curves in 2008 cells 1.9‐fold and 3.3‐fold, respectively. In DDP‐resistant 2008 cells, however, forskolin and IBMX increased the slopes only 1.2 and 2.6‐fold, respectively. These effects of forskolin and IBMX on DDP cytotoxicity did not directly correlate with the effects on the 1‐hr DDP accumulation which suggested that, in addition to modulating DDP accumulation, these agents increase the cytotoxicity of the intracellular platinum. The results indicate that modulation of cAMP levels can have important effects on DDP accumulation and cytotoxicity in 2008 cells and that these effects are significantly diminished in DDP‐resistant cells.

Từ khóa


Tài liệu tham khảo

10.1128/MCB.7.9.3098

Andrews P. A., 1989, The role of membrane potential in cisplatin uptake, Proc. Amer. Ass. Cancer Res., 30, 466

Andrews P. A., 1990, Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance, Cancer Cells, 2, 35

10.1007/978-1-4613-1717-3_26

Andrews P. A., 1988, cis‐Diamminedicnlorpplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells, Cancer Res., 48, 68

Basu A., 1990, Involvement of protein kinase C in phorbol ester‐induced sensitization of HeLa cells to cis‐diamminedichloroplatinum(II), J. biol. Chem., 265, 8451, 10.1016/S0021-9258(19)38909-4

10.1016/0003-2697(76)90527-3

10.1172/JCI114885

Connolly E., 1986, Norepinephrineinduced Na+ influx in brown adipocytes is cyclic‐AMP mediated, J. biol. Chem., 261, 14377, 10.1016/S0021-9258(18)66880-2

10.1016/0002-9378(72)90109-3

10.1016/0020-711X(81)90131-2

10.1038/bjc.1986.168

10.1073/pnas.67.1.305

Hamilton T. C., 1984, Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches, Semin. Oncol., 11, 285

10.1002/ijc.2910420313

10.1126/science.2454506

Isonishi S., 1990, Increased sensitivity to cis‐diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12‐O‐tetradecanoylphorbol‐13‐acetate, J. biol. Chem., 265, 3623, 10.1016/S0021-9258(19)39638-3

Joost H. G., 1988, Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action, Mol. Pharmacol., 33, 449

10.1042/bj2551023

Kraker A. J., 1988, Accumulation of cis‐diamminedichloroplatinum(II) and platinum analogues by platinum‐resistant murine leukemia cells in vitro, Cancer Res., 48, 9

10.1007/BF01871217

Mandel K. G., 1986, Characterization of cyclic AMP‐activated C1− transport pathway in the apical membrane of a human colonic epithelial cell line, J. biol. Chem., 261, 704, 10.1016/S0021-9258(17)36150-1

Mann S. C., 1989, Modulation of cisplatin accumulation by forskolin in human ovarian carcinoma cells, Proc. Amer. Ass. Cancer Res., 30, 466

10.1007/BF00684878

10.1038/325442a0

10.1016/0014-5793(80)80776-9

10.1007/BF01612988

Richon V. M., 1987, Multiple mechanisms of resistance to cis‐diamminedichloroplatinum(II) in murine leukemia L1210 cells, Cancer Res., 47, 2056

Roberts J. J., 1986, Potentiation of sulfur mustard or cisplatin‐induced toxicity by caffeine in Chinese hamster cells correlates with formation of DNA double‐strand breaks during replication on a damaged template, Mutat. Res., 165, 207

10.1016/0076-6879(83)99034-1

10.1016/0006-291X(81)91701-0

10.1073/pnas.78.6.3363

10.1038/313392a0

10.1254/jjp.45.69

Teicher B. A., 1987, III, Characterization of a human squamous carcinoma cell line resistant to cis‐diamminedichloroplatinum(II), Cancer Res., 47, 388

Tomita K., 1989, Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma, Clin. Ther., 11, 43

10.1016/8756-3282(88)90108-1

Wadler S., 1988, Partial reversal of doxorubicin resistance by forskolin and 1,9‐dideoxyforskolin in murine sarcoma S180 variants, Cancer Res., 48, 539

Waud W. R., 1987, Differential uptake of cis‐diamminedichloroplatinum(II) by sensitive and resistant murine L1210 leukemia cells, Cancer Res., 47, 6549

10.1016/0006-2952(83)90334-9

10.1002/1097-0142(19880501)61:9<1741::AID-CNCR2820610904>3.0.CO;2-3

Thông tin
Thông tin xuất bản

International Journal of Cancer

Tập 48 Số 6

866-872

Thông tin tác giả